SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 183.12 |
| Enterprise Value ($M) | -20.25 |
| Book Value ($M) | 131.03 |
| Book Value / Share | 1.82 |
| Price / Book | 1.40 |
| NCAV ($M) | 34.56 |
| NCAV / Share | 0.48 |
| Price / NCAV | 5.30 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.16 |
| Return on Assets (ROA) | -0.10 |
| Return on Equity (ROE) | -0.41 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.73 |
| Current Ratio | 1.73 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 287.07 |
| Assets | 383.54 |
| Liabilities | 252.51 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 49.22 |
| Operating Income | -59.55 |
| Net Income | -36.76 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 22.99 |
| Cash from Investing | -102.81 |
| Cash from Financing | 89.11 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| CLVR – Clever Leaves Holdings Inc. | CLYYF – Celyad Oncology SA |
| CMRA – Comera Life Sciences Holdings, Inc. | CNBX – CNBX Pharmaceuticals Inc. |
| CPMD – CannaPharmaRX, Inc. |
Financial data and stock pages provided by
Fintel.io